Tissue Regenix has signed an additional agreement with Arthrex for pan-European distribution of its BioRinse portfolio, which follows a US agreement signed in March 2018. This provides Tissue Regenix with a significant partner in two key geographies. Arthrex, a global leader in the field of sports medicine, specialises in the marketing of innovative products. Efforts will initially focus on the UK, before gradually launching in other European countries as approvals are gained. The extension of the collaboration should generate material sales growth in the coming years; but, to be conservative, we are maintaining our valuation at £245m (20.9p a share).
13 Nov 2018
Arthrex collaboration extended into Europe
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Arthrex collaboration extended into Europe
Tissue Regenix Group plc (TRX:LON) | 61.5 0 0.0% | Mkt Cap: 43.4m
- Published:
13 Nov 2018 -
Author:
Mick Cooper PhD -
Pages:
3
Tissue Regenix has signed an additional agreement with Arthrex for pan-European distribution of its BioRinse portfolio, which follows a US agreement signed in March 2018. This provides Tissue Regenix with a significant partner in two key geographies. Arthrex, a global leader in the field of sports medicine, specialises in the marketing of innovative products. Efforts will initially focus on the UK, before gradually launching in other European countries as approvals are gained. The extension of the collaboration should generate material sales growth in the coming years; but, to be conservative, we are maintaining our valuation at £245m (20.9p a share).